NeoGenomics, Inc. (NEO) Stock Overview
NASDAQ · Healthcare · Diagnostics & Research
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About NeoGenomics, Inc.
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories.
Source: Yahoo Finance
Sector & Industry
NeoGenomics, Inc. operates in the Healthcare sector, within the Diagnostics & Research industry group. It is listed on the NASDAQ exchange.
NeoGenomics, Inc. at a Glance
| Company | NeoGenomics, Inc. |
| Ticker | NEO |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $17.38 |
| Market cap | $2.23B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$0.39 |
| 52-week high | $19.76 |
| 52-week low | $7.07 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.75 |
| Return on equity (ROE) | -6.33% |
| Debt-to-equity | 57.06% |
| Average volume | 2.85M |
| Shares outstanding | 128.48M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Employees | 2,500 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is NeoGenomics, Inc.'s current P/E ratio?
- NeoGenomics, Inc. (NEO) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is NeoGenomics, Inc.'s market capitalisation?
- NeoGenomics, Inc.'s market cap is $2.23B based on our latest snapshot. See how it ranks by market cap →
- What is NEO's 52-week range?
- Over the past 52 weeks, NEO has traded between $7.07 and $19.76. What does the 52-week range mean? →
- How volatile is NeoGenomics, Inc. compared to the market?
- NeoGenomics, Inc. has a beta of 1.75, meaning it has historically moved more than the broader market. What does beta measure? →
- Does NeoGenomics, Inc. pay a dividend?
- NeoGenomics, Inc. does not currently pay a dividend according to our latest data.
- What exchange is NEO listed on?
- NEO is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is NeoGenomics, Inc. in?
- NeoGenomics, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →